retatrutide nonalcoholic fatty liver disease nash trial A regularly updated website with all most recent clinical trials data in HCV infection Triple hormone receptor agonist retatrutide

So now you are wondering whether you can still use it

A defined off-period lets receptor density and sensitivity recover so the next cycle starts from a fresh baseline rather than a blunted one

14, 223238 (Springer, 1996)

Aydin K, Arusoglu G, Koksal G, Cinar N, Aksoy DY, Yildiz BO (2014) Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome

There is no single right answer, as this comes down to personal preference and health goals

In a 2025 trial , people with obesity (and without diabetes) lost an average of 20.2% of their body weight on Zepbound, compared to 13.7% on Wegovy over 72 weeks